AGA’s recent white paper provides a framework to navigate the latest innovations in obesity care, including GLP-1 receptor agonists, personalized treatment plans and endoscopic, bariatric and metabolic therapies.The new commentary is a follow up to AGA’s 2017 publication, “POWER: Practice Guide on Obesity and Weight Management, Education, and Resources,” and encourages